New Delhi, June 16 -- Iom Bioworks, a deep science startup focused on microbiome-driven healthcare, has raised Rs.4 crore in a seed round led by Inflection Point Ventures (IPV). The investment will support the company's next growth phase, expanding customer outreach, strengthening its IP portfolio, and scaling both its infrastructure and scientific team.

Founded in 2022, Iom Bioworks is advancing the science of gut microbiome modulation by leveraging artificial intelligence and large-scale modelling to deliver personalised health insights. The company's patented platform identifies and targets specific gut bacteria to improve digestion, immunity, metabolism, and mental well-being.

In its first year, Iom Bioworks reached over 500 users, ...